0001127602-12-013887.txt : 20120416
0001127602-12-013887.hdr.sgml : 20120416
20120416162741
ACCESSION NUMBER: 0001127602-12-013887
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120412
FILED AS OF DATE: 20120416
DATE AS OF CHANGE: 20120416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DODION PIERRE F
CENTRAL INDEX KEY: 0001403174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21696
FILM NUMBER: 12761456
MAIL ADDRESS:
STREET 1: ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0305
4
2012-04-12
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001403174
DODION PIERRE F
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
SVP, Corp. Dev. & Operations
Common Stock
2012-04-12
4
S
0
17062
15.3895
D
58770
D
Common Stock
0
I
Wife
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.250 to $15.62, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2012-04-16